Latest Updates
-
Deepika Padukone Wears ₹90,000 Gold Kurta Set As Ranveer Singh, Daughter Dua Twin For Baby Devi’s Name Reveal -
Women, Menopause And Bone Health: Doctor Explains Why Osteoporosis Risk Rises After 40 -
Can Breast Cancer Be Detected Before Symptoms Appear? A Doctor Explains The Role Of Screening -
Papankusha Ekadashi 2026: October 21 Or 22? Know The Correct Date, Tithi And Significance -
OTT Releases This Week (October 19–25): New Movies And Series On Netflix, Prime Video, JioHotstar And Zee5 -
Police Commemoration Day 2026: Know The History, Significance And Programmes Planned Across India This Year -
Deepika Padukone And Ranveer Singh Announce Second Daughter’s Name On Dussehra, Share Family Photo -
Who Was Karthik Sabesh? Tamil Actor Passes Away At 37, Days After Uncle And Composer Deva’s Death -
Who Is Ravleen Varghese? Meet The First Malayali Model To Walk The Victoria’s Secret Runway -
World Osteoporosis Day 2026: A Minor Fall, A Major Fracture — Doctor On Why Older Adults Should Be Careful
Personalized Blood Tests For Cancer Patients

Boffins have used data from the whole genome sequencing of cancer patients to develop individualized blood tests which he believes can help physicians tailor patients' treatments.
"We believe this is the first application of newer generations of whole-genome sequencing that could be clinically useful for cancer patients.Using this approach, we can develop biomarkers for potentially any cancer patient." says Victor Velculescu, M.D., Ph.D., associate professor of oncology and co-director of the cancer biology Johns Hopkins."
In a report on the work, published in the February 24 issue of Science Translational Medicine, show that unlike any other kind researches they are studying the rearrangements of large chunks of DNA rather than changes in a single DNA letter among billions of others. They term it their new approach Personalized Analysis of Rearranged Ends (PARE).
Such DNA rearrangements are widely known to occur exclusively in cancer cells, not normal ones, making them ideal biomarkers for cancer.
Using six sets of cancerous and normal tissue samples taken from four colorectal and two breast cancer patients, the Johns Hopkins team used next-generation DNA sequencing methods to catalogue the genome sequence data of each patient.
After investigators identified DNA rearrangements in patients' tumor samples, they looked for similar changes in DNA shed from tumors into the patients' blood.
Taking and matching these samples, they amplified DNA found in the blood and determined that these tests were sensitive enough to detect rearranged tumor DNA in these samples.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
